First Header Logo Second Header Logo

Connection

Steven Mizel to Mice

This is a "connection" page, showing publications Steven Mizel has written about Mice.
Connection Strength

0.605
  1. Delaney KN, Phipps JP, Johnson JB, Mizel SB. A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice. Viral Immunol. 2010 Apr; 23(2):201-10.
    View in: PubMed
    Score: 0.052
  2. Weimer ET, Ervin SE, Wozniak DJ, Mizel SB. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa. Vaccine. 2009 Nov 12; 27(48):6762-9.
    View in: PubMed
    Score: 0.050
  3. Bates JT, Uematsu S, Akira S, Mizel SB. Direct stimulation of tlr5+/+ CD11c+ cells is necessary for the adjuvant activity of flagellin. J Immunol. 2009 Jun 15; 182(12):7539-47.
    View in: PubMed
    Score: 0.049
  4. Weimer ET, Lu H, Kock ND, Wozniak DJ, Mizel SB. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Infect Immun. 2009 Jun; 77(6):2356-66.
    View in: PubMed
    Score: 0.048
  5. Mizel SB, Graff AH, Sriranganathan N, Ervin S, Lees CJ, Lively MO, Hantgan RR, Thomas MJ, Wood J, Bell B. Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol. 2009 Jan; 16(1):21-8.
    View in: PubMed
    Score: 0.047
  6. Bates JT, Honko AN, Graff AH, Kock ND, Mizel SB. Mucosal adjuvant activity of flagellin in aged mice. Mech Ageing Dev. 2008 May; 129(5):271-81.
    View in: PubMed
    Score: 0.045
  7. Honko AN, Sriranganathan N, Lees CJ, Mizel SB. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun. 2006 Feb; 74(2):1113-20.
    View in: PubMed
    Score: 0.039
  8. West AP, Dancho BA, Mizel SB. Gangliosides inhibit flagellin signaling in the absence of an effect on flagellin binding to toll-like receptor 5. J Biol Chem. 2005 Mar 11; 280(10):9482-8.
    View in: PubMed
    Score: 0.036
  9. Honko AN, Mizel SB. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect Immun. 2004 Nov; 72(11):6676-9.
    View in: PubMed
    Score: 0.035
  10. Mizel SB, Honko AN, Moors MA, Smith PS, West AP. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J Immunol. 2003 Jun 15; 170(12):6217-23.
    View in: PubMed
    Score: 0.032
  11. Moors MA, Li L, Mizel SB. Activation of interleukin-1 receptor-associated kinase by gram-negative flagellin. Infect Immun. 2001 Jul; 69(7):4424-9.
    View in: PubMed
    Score: 0.028
  12. Clark KM, Johnson JB, Kock ND, Mizel SB, Parks GD. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge. Virology. 2011 Oct 25; 419(2):97-106.
    View in: PubMed
    Score: 0.014
  13. Chedid M, Yoza BK, Brooks JW, Mizel SB. Activation of AP-1 by IL-1 and phorbol esters in T cells. Role of protein kinase A and protein phosphatases. J Immunol. 1991 Aug 01; 147(3):867-73.
    View in: PubMed
    Score: 0.014
  14. Carruth LM, Demczuk S, Mizel SB. Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. J Biol Chem. 1991 Jul 05; 266(19):12162-7.
    View in: PubMed
    Score: 0.014
  15. Ahmed M, Puckett S, Arimilli S, Braxton CL, Mizel SB, Lyles DS. Stimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin. J Virol. 2010 Nov; 84(22):12093-8.
    View in: PubMed
    Score: 0.013
  16. Braxton CL, Puckett SH, Mizel SB, Lyles DS. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens. J Virol. 2010 Apr; 84(7):3552-61.
    View in: PubMed
    Score: 0.013
  17. Minnich-Carruth LL, Suttles J, Mizel SB. Evidence against the existence of a membrane form of murine IL-1 alpha. J Immunol. 1989 Jan 15; 142(2):526-30.
    View in: PubMed
    Score: 0.012
  18. Mizel SB, Kilian PL, Lewis JC, Paganelli KA, Chizzonite RA. The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. J Immunol. 1987 May 01; 138(9):2906-12.
    View in: PubMed
    Score: 0.011
  19. DeLuca D, Mizel SB. I-A-positive nonlymphoid cells and T cell development in murine fetal thymus organ cultures: interleukin 1 circumvents the block in T cell differentiation induced by monoclonal anti-I-A antibodies. J Immunol. 1986 Sep 01; 137(5):1435-41.
    View in: PubMed
    Score: 0.010
  20. Markham RB, Pier GB, Goellner JJ, Mizel SB. In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing. J Immunol. 1985 Jun; 134(6):4112-7.
    View in: PubMed
    Score: 0.009
  21. Giri JG, Lomedico PT, Mizel SB. Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1. J Immunol. 1985 Jan; 134(1):343-9.
    View in: PubMed
    Score: 0.009
  22. Mizel SB, Rosenstreich DL. Regulation of lymphocyte-activating factor (LAF) production and secretion in P388D1 cells: identification of high molecular weight precursors of LAF. J Immunol. 1979 Jun; 122(6):2173-9.
    View in: PubMed
    Score: 0.006
  23. Mizel SB, Oppenheim JJ, Rosenstreich DL. Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes. J Immunol. 1978 May; 120(5):1497-503.
    View in: PubMed
    Score: 0.006
  24. Moldawer LL, Lonnroth C, Mizel SB, Lundholm KG. Down-regulation of interleukin 1 production by macrophages of sarcoma-bearing mice. J Immunol. 1987 Jun 15; 138(12):4270-4.
    View in: PubMed
    Score: 0.003
  25. Kaye J, Gillis S, Mizel SB, Shevach EM, Malek TR, Dinarello CA, Lachman LB, Janeway CA. Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol. 1984 Sep; 133(3):1339-45.
    View in: PubMed
    Score: 0.002
  26. Howard M, Mizel SB, Lachman L, Ansel J, Johnson B, Paul WE. Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation. J Exp Med. 1983 May 01; 157(5):1529-43.
    View in: PubMed
    Score: 0.002
  27. Rao A, Mizel SB, Cantor H. Disparate functional properties of two interleukin 1-responsive Ly-1+2- T cell clones: distinction of T cell growth factor and T cell-replacing factor activities. J Immunol. 1983 Apr; 130(4):1743-8.
    View in: PubMed
    Score: 0.002
  28. Sztein MB, Vogel SN, Sipe JD, Murphy PA, Mizel SB, Oppenheim JJ, Rosenstreich DL. The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol. 1981 Sep 01; 63(1):164-76.
    View in: PubMed
    Score: 0.002
  29. Farrar JJ, Mizel SB, Fuller-Farrar J, Farrar WL, Hilfiker ML. Macrophage-independent activation of helper T cells. I. Production of Interleukin 2. J Immunol. 1980 Aug; 125(2):793-8.
    View in: PubMed
    Score: 0.002
  30. Farrar WL, Mizel SB, Farrar JJ. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. J Immunol. 1980 Mar; 124(3):1371-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.